Australia markets closed
  • ALL ORDS

    7,324.90
    +36.10 (+0.50%)
     
  • AUD/USD

    0.7073
    -0.0052 (-0.73%)
     
  • ASX 200

    7,064.30
    +31.80 (+0.45%)
     
  • OIL

    91.03
    -1.06 (-1.15%)
     
  • GOLD

    1,803.50
    -12.00 (-0.66%)
     
  • BTC-AUD

    34,044.89
    -1,289.41 (-3.65%)
     
  • CMC Crypto 200

    573.82
    +2.53 (+0.44%)
     

Global COVID-19 Vaccination Market Outlook 2022-2026 - ResearchAndMarkets.com

·2-min read

DUBLIN, December 06, 2021--(BUSINESS WIRE)--The "Global Covid-19 Vaccination Market 2022-2026" report has been added to ResearchAndMarkets.com's offering.

The COVID-19 vaccination market is expected to reduce by $ 68.35 billion during 2022-2026.

The report on the COVID-19 vaccination market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as key vendor analysis.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment.

The market is driven by the increasing incidence of COVID-19 infection and favorable government initiatives. This study identifies the rising awareness about efficient vaccination as one of the prime reasons driving the COVID-19 vaccination market growth during the next few years.

The Covid-19 vaccination market analysis includes the application segment and geographic landscape.

The Covid-19 vaccination market is segmented as below:

By Application

  • mRNA

  • others

By Geographical Landscape

  • North America

  • Asia

  • Europe

  • ROW

The report on COVID-19 vaccination market covers the following areas:

  • COVID-19 vaccination market sizing

  • COVID-19 vaccination market forecast

  • COVID-19 vaccination market industry analysis

Key Topics Covered:

Executive Summary

  • Market overview

Market Landscape

  • Market ecosystem

  • Value chain analysis

Market Sizing

  • Market definition

  • Market segment analysis

  • Market size 2021

  • Market outlook: Forecast for 2021 - 2026

Five Forces Analysis

  • Bargaining power of buyers

  • Bargaining power of suppliers

  • Threat of new entrants

  • Threat of substitutes

  • Threat of rivalry

  • Market condition

Market Segmentation by Application

  • Market segments

  • Comparison by Application

  • mRNA - Market size and forecast 2021-2026

  • Others - Market size and forecast 2021-2026

  • Market opportunity by Application

Customer landscape

Geographic Landscape

  • Geographic segmentation

  • Geographic comparison

  • North America - Market size and forecast 2021-2026

  • Asia - Market size and forecast 2021-2026

  • Europe - Market size and forecast 2021-2026

  • ROW - Market size and forecast 2021-2026

  • Key leading countries

  • Market opportunity By Geographical Landscape

  • Market drivers

  • Market challenges

  • Market trends

Vendor Landscape

  • Landscape disruption

Vendor Analysis

  • AstraZeneca Plc

  • Bharat Biotech Ltd.

  • China National Pharmaceutical Group Corp.

  • Gamaleya National Center

  • Inovio Pharmaceuticals Inc.

  • Johnson and Johnson Inc.

  • Moderna Inc.

  • Novavax Inc.

  • Pfizer Inc.

  • Sinovac Biotech Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/oveba5

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211206005356/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting